CONCURRENT DEXAMETHASONE LIMITS THE CLINICAL BENEFIT OF IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA

被引：0

作者：

Iorgulescu, Bryan ^{[1
]}

Gokhale, Prafulla ^{[2
]}

Speranza, Maria ^{[2
]}

Eschle, Benjamin ^{[2
]}

Poitras, Michael ^{[2
]}

Wilkens, Margaret ^{[2
]}

Soroko, Kara ^{[2
]}

Chhoeu, Chhayheng ^{[2
]}

Knott, Aine ^{[2
]}

Gao, Yang ^{[2
]}

Lim-Fat, Mary Jane ^{[2
]}

Baker, Gregory ^{[3
]}

Bonal, Dennis ^{[4
]}

Quang-De Nguyen ^{[4
]}

Grant, Gareth ^{[2
]}

Ligon, Keith ^{[5
]}

Sorger, Peter ^{[6
]}

Chiocca, E. Antonio ^{[1
,3
]}

Anderson, Ana ^{[1
]}

Kirschmeier, Paul ^{[2
]}

Sharpe, Arlene ^{[3
]}

Freeman, Gordon ^{[2
]}

Reardon, David ^{[7
]}

机构：

[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Boston, MA USA

[3] Harvard Med Sch, Boston, MA 02115 USA

[4] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Ctr Biomed Imaging Oncol, Boston, MA 02115 USA

[5] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA

[6] Harvard Program Therapeut Sci, Lab Syst Pharmacol, Boston, MA USA

[7] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA

来源：

NEURO-ONCOLOGY | 2020年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

IMMU-09

引用

页码：106 / 106

页数：1

共 50 条

[1] Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma
Iorgulescu, J. Bryan
Gokhale, Prafulla C.
Speranza, Maria C.
Eschle, Benjamin K.
Poitras, Michael J.
Wilkens, Margaret K.
Soroko, Kara M.
Chhoeu, Chhayheng
Knott, Aine
Gao, Yan
Lim-Fat, Mary Jane
Baker, Gregory J.
Bonal, Dennis M.
Nguyen, Quang-De
Grant, Gareth R. L.
Ligon, Keith L.
Sorger, Peter K.
Chiocca, E. Antonio
Anderson, Ana C.
Kirschmeier, Paul T.
Sharpe, Arlene H.
Freeman, Gordon J.
Reardon, David A.
[J]. CLINICAL CANCER RESEARCH, 2021, 27 (01) : 276 - 287
[2] Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
Russell Maxwell
Christopher M. Jackson
Michael Lim
[J]. Current Treatment Options in Oncology, 2017, 18
[3] Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
Maxwell, Russell
Jackson, Christopher M.
Lim, Michael
[J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2017, 18 (08)
[4] PRECLINICAL MECHANISTIC AND CLINICAL EVALUATION OF THE CORTICOSTEROID DEXAMETHASONE'S DETRIMENTAL EFFECTS ON IMMUNE CHECKPOINT BLOCKADE IN GLIOBLASTOMA CANCER
Iorgulescu, Bryan
Gokhale, Prafulla
Speranza, Maria
Eschle, Benjamin
Poitras, Michael
Wilkens, Margaret
Soroko, Kara
Chhoeu, Chhayheng
Knott, Aine
Gao, Yan
Lim-Fat, Mary Jane
Baker, Gregory
Bonal, Dennis
Quang-De Nguyen
Grant, Gareth
Ligon, Keith
Sorger, Peter
Chiocca, E.
Anderson, Ana
Kirschmeier, Paul
Sharpe, Arlene
Freeman, Gordon
Reardon, David
[J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A123 - A126
[5] The Current Landscape of Immune Checkpoint Blockade in Glioblastoma
Akintola, Oluwatosin O.
Reardon, David A.
[J]. NEUROSURGERY CLINICS OF NORTH AMERICA, 2021, 32 (02) : 235 - 248
[6] Molecular responses to immune checkpoint blockade in glioblastoma
Hirotaka Ito
Hiroshi Nakashima
E. Antonio Chiocca
[J]. Nature Medicine, 2019, 25 : 359 - 361
[7] Molecular responses to immune checkpoint blockade in glioblastoma
Ito, Hirotaka
Nakashima, Hiroshi
Chiocca, E. Antonio
[J]. NATURE MEDICINE, 2019, 25 (03) : 359 - 361
[8] Immune Checkpoint Blockade Biology in Mouse Models of Glioblastoma
Yeo, Alan T.
Charest, Alain
[J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (09) : 2516 - 2527
[9] Treatment Progress of Immune Checkpoint Blockade Therapy for Glioblastoma
Zhang, Na
Wei, Li
Ye, Meng
Kang, Chunsheng
You, Hua
[J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
[10] Glioblastoma Eradication by Combination Oncolytic Immunovirotherapy and Immune Checkpoint Blockade
Saha, Dipongkor
Martuza, Robert L.
Rabkin, Samuel D.
[J]. MOLECULAR THERAPY, 2017, 25 (05) : 361 - 361

← 1 2 3 4 5 →